SEC Company Response from iBio, Inc. (IBIO) (CIK 0001420720) (IBIO) — Aug 10, 2017
iBio, Inc. (IBIO) (CIK 0001420720)
Date: Aug. 10, 2017 · CIK: 0001420720 · Accession: 0001144204-17-041972
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-219725
Letter
IBIO, INC.
600 Madison Avenue, Suite 1601
New York, NY 10022-1737
VIA EDGAR
August 10, 2017
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention:
RE: iBio, Inc.
Registration Statement on Form S-1 (File No. 333-219725)
Acceleration Request
Ladies and Gentlemen:
Pursuant to Rule 461, iBio, Inc. (the “Company”) hereby requests the Securities and Exchange Commission to accelerate the effective date of the above-referenced Registration Statement and declare the Registration Statement effective as of 4:30 p.m., Washington, D.C. time, on Friday, August 11, 2017 or as soon thereafter as practicable.
Sincerely,
IBIO, INC.
Show Raw Text
CORRESP
1
filename1.htm
IBIO, INC.
600 Madison Avenue, Suite 1601
New York, NY 10022-1737
VIA EDGAR
August 10, 2017
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention:
RE:
iBio, Inc.
Registration Statement on Form S-1 (File No. 333-219725)
Acceleration Request
Ladies and Gentlemen:
Pursuant to Rule 461,
iBio, Inc. (the “Company”) hereby requests the Securities and Exchange Commission to accelerate the effective date
of the above-referenced Registration Statement and declare the Registration Statement effective as of 4:30 p.m., Washington, D.C.
time, on Friday, August 11, 2017 or as soon thereafter as practicable.
Sincerely,
IBIO, INC.
By:
/s/ Robert B. Kay
Name:
Robert B. Kay
Title:
Executive Chairman and Chief Executive Officer